Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients

Patients with myeloproliferative neoplasms (MPN) are known to have higher incidence of nonhematological second primary malignancies (SPM) compared to general population. In the MYSEC study on 781 secondary myelofibrosis (SMF) patients, the incidence of SPM after SMF diagnosis resulted 0.98/100 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Mora, Barbara, Rumi, Elisa, Guglielmelli, Paola, Barraco, Daniela, Maffioli, Margherita, Rambaldi, Alessandro, Caramella, Marianna, Komrokji, Rami, Gotlib, Jason, Kiladjian, Jean Jacques, Cervantes, Francisco, Devos, Timothy, Palandri, Francesca, De Stefano, Valerio, Ruggeri, Marco, Silver, Richard T., Benevolo, Giulia, Albano, Francesco, Cavalloni, Chiara, Pietra, Daniela, Barbui, Tiziano, Rotunno, Giada, Cazzola, Mario, Vannucchi, Alessandro Maria, Giorgino, Toni, Passamonti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675726/
https://www.ncbi.nlm.nih.gov/pubmed/31173472
http://dx.doi.org/10.1002/cam4.2107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675726/
https://www.ncbi.nlm.nih.gov/pubmed/31173472
http://dx.doi.org/10.1002/cam4.2107

Ejemplares similares